Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.
about
Pathophysiological mechanisms of death resistance in colorectal carcinomaAn intravenous (i.v.) route-compatible formulation of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, improves FL118 antitumor efficacy and therapeutic index (TI)Fluoropyrimidine ActivityEvaluation of the Expression of the Inhibitor of Apoptosis Protein Family and Human Telomerase Reverse Transcriptase in Patients With Advanced Colorectal Adenoma.A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells.Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation.Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthaseGenome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancersFolic Acid-Metabolizing Enzymes Regulate the Antitumor Effect of 5-Fluoro-2'-Deoxyuridine in Colorectal Cancer Cell Lines.How many diseases are colorectal cancer?Genetic polymorphisms in SLC23A2 as predictive biomarkers of severe acute toxicities after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.cIAP2 as a therapeutic target in colorectal cancer and other malignancies.Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer.Effect of NIMA-related kinase 2B on the sensitivity of breast cancer to paclitaxel in vitro and vivo.Promoter demethylation of nuclear factor-erythroid 2-related factor 2 gene in drug-resistant colon cancer cells.Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects.Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma.Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy.Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin.MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.Downregulation of ABCE1 via siRNA affects the sensitivity of A549 cells against chemotherapeutic agents.A critical role for cellular inhibitor of protein 2 (cIAP2) in colitis-associated colorectal cancer and intestinal homeostasis mediated by the inflammasome and survival pathways.Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance.
P2860
Q26778007-1EB53F7A-3497-4D91-A0A6-31651AA56A44Q28485864-12A3C184-786C-4E4F-8625-C5C7A072B83CQ29883401-E69C0383-D363-467A-9194-02D26193561FQ33888082-1EC4BF1C-AF23-4EC7-8C57-725807110F3AQ34043011-70AD6B05-6F95-4A8D-B97A-CD64BB6B6404Q35056092-C3E43612-CE4F-4D01-9CC3-FC8F869E1FE1Q35097256-4BB88A50-A781-4CD7-B46A-4D95D2C9FBA7Q35161704-FD96038E-2B2B-4B01-9681-7A74AEB83BDCQ35600924-E98C5427-F402-4656-BAC6-8626823A8F84Q36148634-4A148DFA-AC99-4275-AB13-036AB23C350EQ36238965-0578D0D1-1EAE-46E5-BF29-DD1380B14ADAQ37605384-C62AC0CA-DD1B-4E6B-BE59-ED7CE025DF19Q37605889-58F4FBCA-AEC1-4455-967C-E99BC0517417Q37832190-CE09FBDA-7DD7-401C-AA1A-D443DDB3C8BAQ38704755-21C6B989-8A50-4E1C-8AFC-906118E5B2FCQ38815478-FE09679E-F46C-4F26-9D68-9F0BA4880D82Q38997864-269348E6-E292-49A6-ACAF-7497AB215BBEQ39079636-1A778F30-C1A8-4666-A790-7F96E3369887Q39387335-8EEF67D5-2778-496E-A2F4-6D598F2856E4Q39406631-D545BEDF-85F6-4B0B-8BDA-B2CAB62D9BEBQ39467214-EF114EFB-F703-47A5-95A4-8599DA783C00Q42949488-5FEC034C-1DDA-488B-B216-C8A0384CB7F7Q43247077-652E6612-C4C2-4AB8-860B-A83695A99823Q43522938-80BCE3B0-6C17-4C0C-A318-AF27DC535846Q51001472-4F01F396-5531-49CA-99FE-BCFF13053CB6Q54268307-589E84FF-A6C2-4074-873F-CEE4C971E435Q55480165-979431D9-9EDA-4DD3-9E6D-8B4864CA403A
P2860
Down-regulation of cIAP2 enhances 5-FU sensitivity through the apoptotic pathway in human colon cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Down-regulation of cIAP2 enhan ...... y in human colon cancer cells.
@en
Down-regulation of cIAP2 enhan ...... y in human colon cancer cells.
@nl
type
label
Down-regulation of cIAP2 enhan ...... y in human colon cancer cells.
@en
Down-regulation of cIAP2 enhan ...... y in human colon cancer cells.
@nl
prefLabel
Down-regulation of cIAP2 enhan ...... y in human colon cancer cells.
@en
Down-regulation of cIAP2 enhan ...... y in human colon cancer cells.
@nl
P2093
P2860
P1433
P1476
Down-regulation of cIAP2 enhan ...... y in human colon cancer cells.
@en
P2093
Akihiro Yamamura
Chikashi Shibata
Hideaki Karasawa
Hiroyuki Sasaki
Iwao Sasaki
Kazuhiro Takami
Kazuyuki Ishida
Makoto Kinouchi
Mitsunori Okabe
Naoyuki Kaneko
P2860
P304
P356
10.1111/J.1349-7006.2009.01112.X
P50
P577
2009-03-02T00:00:00Z